{{Rsnum
|rsid=3764383
|Gene=BIRC5
|Chromosome=17
|position=78212770
|Orientation=minus
|GMAF=0.2195
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BIRC5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.0 | 39.8 | 6.2
| HCB | 58.4 | 38.7 | 2.9
| JPT | 61.9 | 34.5 | 3.5
| YRI | 85.0 | 15.0 | 0.0
| ASW | 61.4 | 38.6 | 0.0
| CHB | 58.4 | 38.7 | 2.9
| CHD | 62.4 | 32.1 | 5.5
| GIH | 40.6 | 44.6 | 14.9
| LWK | 73.6 | 25.5 | 0.9
| MEX | 69.0 | 31.0 | 0.0
| MKK | 71.2 | 25.0 | 3.8
| TSI | 47.1 | 42.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20057973
|Title=Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer
|OA=1
}}

{{PMID Auto
|PMID=20881643
|Title=Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}